Association between changes in serum level of fibroblast growth factor 23 and treatment in patients undergoing peritoneal dialysis

Association between changes in serum level of fibroblast growth factor 23 and treatment in patients undergoing peritoneal dialysis - Association between changes in serum level of fibroblast growth factor 23 and treatment in patients undergoing peritoneal dialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019095

Enrollment

Registered

2015-10-01

Start date

2015-09-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endstage Kidney Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 1) who were registered to Fukuoka Peritoneal Dialysis Registry, 2) received peritoneal dialysis at Kyushu University, and 3) had frozen serum at baseline and at 18 month

Exclusion criteria

Exclusion criteria: Patients who recieved both hemodialysis and peritoneal dialysis therapy

Design outcomes

Primary

Measure	Time frame
Changes in serum fibroblast growth factor 23 level	—

Countries

Japan

Contacts

Public ContactShunsuke Yamada

Kyushu University Department of Medicine and Clinical Science

ana65641@nifty.com092-642-5843

Outcome results